Biologic Drugs With Mechanism of Action: HER2/Neu/cerbB2 Antagonists
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: HER2/Neu/cerbB2 Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 1998-09-25 | ⤷ Sign Up | ⤷ Sign Up |
Genentech, Inc. | PERJETA | pertuzumab | Injection | 125409 | 2012-06-08 | ⤷ Sign Up | ⤷ Sign Up |
Amgen, Inc. | KANJINTI | trastuzumab-anns | For Injection | 761073 | 2019-06-13 | ⤷ Sign Up | ⤷ Sign Up |
Mylan Pharmaceuticals Inc. | OGIVRI | trastuzumab-dkst | For Injection | 761074 | 2017-12-01 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |